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Alterations in adult neurogenesis have been noted in the brain of HIV-infected individuals and are likely linked to HIV-associated
neurocognitive deficits, including those in learning and memory. But the underlying molecular mechanisms are not fully under-
stood. In the study, we took advantage of doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) and
determined the relationship between Tat expression and neurogenesis. Tat expression in astrocytes was associated with fewer
neuron progenitor cells (NPCs), fewer immature neurons, and fewer mature neurons in the dentate gyrus of the hippocampus of
the mouse brain. In vitro NPC-derived neurosphere assays showed that Tat-containing conditioned media from astrocytes or
recombinant Tat protein inhibited NPC proliferation and migration and altered NPC differentiation, while immunodepletion of
Tat from Tat-containing conditioned media or heat inactivation of recombinant Tat abrogated those effects. Notch signaling
downstream gene Hes1 promoter-driven luciferase reporter gene assay and Western blotting showed that recombinant Tat or
Tat-containing conditioned media activated Hes1 transcription and protein expression, which were abrogated by Tat heat inacti-
vation, immunodepletion, and cysteine mutation at position 30. Last, Notch signaling inhibitor N-[N-(3,5-difluorophenacetyl)-L-
alanyl]-S-phenylglycine t-butyl ester (DAPT) significantly rescued Tat-impaired NPC differentiation in vitro and neurogenesis in
vivo. Together, these results show that Tat adversely affects NPCs and neurogenesis through Notch signaling and point to the
potential of developing Notch signaling inhibitors as HIV/neuroAIDS therapeutics.
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Introduction
Neurogenesis is a highly regulated developmental process and
involves proliferation, migration, differentiation, and matura-
tion of neuron progenitor cells (NPCs). This process continues
throughout adult life in the subventricular zone of the lateral
ventricle to generate interneurons in the olfactory bulb and in the
subgranular zone of the dentate gyrus to generate granule cells in
the hippocampus (Ming and Song, 2005; Lledo et al., 2006).
Adult neurogenesis in the hippocampus is involved in mainte-
nance of the cognitive functions, such as learning and memory,
and is regulated by physiological and pathological stimuli (Fuchs
and Gould, 2000; Ming and Song, 2005; Leuner et al., 2006).
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Significance Statement
HIV infection of the CNS causes cognitive and memory deficits, which have become more prevalent in the era of combination
antiretroviral therapy (cART). Neurogenesis is impaired in HIV-infected individuals. But the underlying molecular mechanisms
remain largely unknown. In this study, we have discovered that HIV Tat impairs neurogenesis through the Notch signaling
pathway. These findings are particularly important because Tat protein has recently been detected in the brain of HIV-infected
individuals with HIV replication in the periphery being effectively controlled by cART. The current study not only further high-
lights the importance of HIV Tat protein in HIV/neuroAIDS, but also presents a new strategy to develop novel HIV/neuroAIDS
therapeutics, particularly in the era of cART.
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HIV infection of the CNS often leads to cognitive, motor, and
neurobehavioral dysfunction (Epstein et al., 1986; Valcour et al.,
2004; Dube´ et al., 2005). In the era of combination antiretroviral
therapy (cART),minor cognitive andmotor disorder (MCMD) has
become increasingly prevalent (Ellis et al., 1997; Kaul et al., 2001,
2005). Impairedneurogenesishasbeennoted in thehippocampusof
HIV-infected individuals, simian immunodeficiency virus-infected
macaques, and severe combined immunodeficiency mice injected
with HIV-infected humanmacrophages/microglia (Krathwohl and
Kaiser, 2004a,b; Poluektova et al., 2005; Curtis et al., 2014). Several
putativemechanisms are proposed forHIV-impaired neurogenesis.
HIV infection of macrophages/microglia and astrocytes alters ex-
pression of cytokines or growth factors (Lee et al., 2002; Vallie`res et
al., 2002; Sairanen et al., 2005; Iosif et al., 2006; Peng et al., 2008),
several of which are known to affect adult hippocampal neurogen-
esis.HIV could have effects onNPCs through direct infection (Law-
rence et al., 2004; Tran et al., 2005; Schwartz and Major, 2006;
Whitney et al., 2009). HIV has been shown to inhibit proliferation
and promote quiescence of NPCs (Krathwohl and Kaiser, 2004a;
Okamoto et al., 2007) and NPC migration (Belmadani et al., 2005,
2006).HIV gp120 expression has been shown to inhibitNPCprolif-
eration in vitro and in gp120-expressing transgenic mice (Okamoto
et al., 2007). Currently, there have been no effective therapies to
reduce, prevent, or reverseMCMD.Thus, a better understanding of
the cellular and molecular mechanisms for HIV-impaired neuro-
genesis is needed.
HIV Tat protein is a major pathogenic factor in HIV/neu-
roAIDS, as its expression alone in the brain is sufficient to result
in neuropathological and neurobehavioral changes reminiscent
of those inHIV-infected individuals (Kim et al., 2003; Paris et al.,
2014). HIV Tat is secreted from HIV-infected cells (Westendorp
et al., 1995; Xiao et al., 2000) and taken up by uninfected cells
(Frankel and Pabo, 1988;Mann and Frankel, 1991; Bonifaci et al.,
1995; Liu et al., 2000). Tat transcripts are elevated in HIV-
demented brain andTat protein is detected inHIV-infected brain
(Parmentier et al., 1992; Cupp et al., 1993; Kolson et al., 1993;
Bratanich et al., 1998). Tat protein has been shown to affect ma-
ture neurons in a variety of ways (Chen et al., 1997; Cheng et al.,
1998; Conant et al., 1998; Jones et al., 1998; Zidovetzki et al.,
1998; Hofman et al., 1999) and inhibit NPC proliferation and
differentiation in vitro (Mishra et al., 2010; Yao et al., 2012).
Given the recent finding that Tat is persistently expressed in the
brain of HIV-infected individuals treated with cART (Johnson et
al., 2013), it is imperative to determine effects of Tat expression in
neurogenesis and its contribution to HIV-associated MCMD.
In this study, we took advantage of the unique doxycycline-
inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat)
and the nestin promoter-driven green fluorescence protein mice
(nestin-GFP) and assessed Tat effects during all stages of neurogen-
esis. In addition, we also attempted to delineate themolecular path-
ways involving Tat interaction with NPCs and neurogenesis.
Materials andMethods
Animals and tissues. Wild-type C57BL/6 mice (WT) were purchased
from the Jackson Laboratory. Doxycycline (Dox)-inducible astrocyte-
specific HIV-1 Tat transgenic mice (iTat) were created in our laboratory
as described previously (Kim et al., 2003; Zou et al., 2007). Nestin
promoter-driven green fluorescence protein transgenic mice (nestin-
GFP) were obtained fromDr. Grigori Enikolopov of Cold SpringHarbor
Laboratory, Cold Spring Harbor, New York (Mignone et al., 2004). iTat/
nestin-GFPmice were generated by cross breeding nestin-GFPmice with
iTat mice. In vivoNPC proliferation was determined as described previ-
ously (Okamoto et al., 2007). Briefly, 4-week-oldmice (n 6 each group;
3male, 3 female)were intraperitoneally injectedwithDox [80mg/kg/d in
double-distilled H2O (ddH2O), pH 2.8; Sigma-Aldrich] for 3 d and Dox
plus bromodeoxyridine (BrdU; 50 mg/kg/d in ddH2O; Sigma-Aldrich)
for 4 d. Mouse brains were collected 24 h after the final injection and
sectioned for floating staining. In vivo neurogenesis was determined as
described previously (Chen et al., 2004). Briefly, 8-week-old mice (n 6
each group; 3 male, 3 female) were intraperitoneally injected with Dox
(80 mg/kg/d in ddH2O, pH 2.8) for 3 d, Dox plus BrdU (50 mg/kg/d in
ddH2O) for 4 d, andBrdU alone for 3 d.Mouse brainswere collected 25 d
after the final injection and sectioned for floating staining. For in vivo
neurogenesis involvingNotch inhibitorN-[N-(3,5-difluorophenacetyl)-
L-alanyl]-S-phenylglycine t-butyl ester (DAPT; Cristofaro et al., 2013),
DAPT (120 mg/kg/d in 5% ethanol/95% corn oil; ApexBio) was cointra-
peritoneally injected with Dox for 3 d and Dox, DAPT plus BrdU for 4 d,
and BrdU alone for 3 d.
Cells and cell cultures. We purchased 293T cells from the American
Tissue Culture Collection. These were maintained in DMEM (Sigma-
Aldrich), supplemented with 10% fetal bovine serum (FBS; Atlanta Bio-
logicals), 50 U/ml penicillin, and 50 g/ml streptomycin in a 37°C, 5%
CO2 incubator. Human primary astrocytes were isolated from a 6-week-
old aborted human fetus as described previously (Liu et al., 2014).Mouse
primary astrocytes were isolated from the embryonic day (E) 18.5 brain
and induced to express Tat as described previously (Zhou et al., 2004).
Primary astrocytes were cultured in F12-Kmedium (Cellgro) containing
10% FBS, 50 U/ml penicillin, and 50 g/ml streptomycin in a 37°C, 5%
CO2 incubator. Cells were passaged every 3 d. Mouse neuron progenitor
cells (NPCs) were isolated from neonatal mouse pups (postnatal day 1;
Xie et al., 2014). Briefly, brains were dissected and trypsinized into single
cells by usingTrypLE (Invitrogen). Cells were seeded in nontreated plates
and maintained in the NPC medium: Neurobasal-A medium (Invitro-
gen) supplementedwith 1%B27, 20 ng/ml EGF, 20 ng/ml bFGF, 50U/ml
penicillin, and 50 g/ml streptomycin in a 37°C, 5% CO2 incubator.
NPCs began to form neurospheres after 7 d and were passaged every 7 d.
Plasmids and transfection. pcDNA3 and pCMV--gal plasmids were
purchased fromClontech. pTat.Myc was previously described (Liu et al.,
2002). pHes1-Luc plasmid was kindly provided by Dr. Nadia Carlesso of
the Indiana University School of Medicine. pLTR-Luc [donated by Drs.
R. Jeeninga and B. Berkhout (Klaver and Berkhout, 1994; Jeeninga et al.,
2000)] and pE-Tat.BL43.CC, pE-Tat.BL43.CS, and pE-Tat.BL43.SS [do-
nated by Dr. Udaykumar Ranga (Ranga et al., 2004; Mishra et al., 2008)]
were obtained through the National Institutes of Health (NIH) AIDS
Reagent Program. For transfection, cells were plated in a 60mmdish at a
density of 1 106 cells/dish or in a 24-well plate at a density of 1 105
cells/well, cultured for 24 h, and then transfected with plasmids (8g per
60 mm dish or 0.8 g per well) using standard calcium phosphate pre-
cipitation methods. Cells were harvested for protein analysis 72 h after
transfection.
In vitro NPC proliferation assay. In vitro NPC proliferation assay was
performed essentially as described previously (Mishra et al., 2010).
Briefly, neurospheres derived from NPCs at the seventh day of cultures
were trypsinized into single cells by using TrypLE (Thermo Fisher Scien-
tific). Those cells were plated in a nontreated 12-well plate (Corning) at a
density of 2  105 cells/well and cultured in the presence of Tat-
containing conditioned media or recombinant Tat protein (NIH AIDS
Reagents Program; donated by Division of AIDS, National Institute of
Allergy and Infectious Diseases) for 7 d. Images of the neurospheres were
taken using a Nikon Eclipse Ti microscope, and the diameters of the
neurospheres were measured and analyzed using a NIS-Elements viewer
4.20 software (Nikon). For comparison, neurospheres were separated
into two groups (Mishra et al., 2010): small neurospheres (diameter,60
m) and large neurospheres (diameter,60 m).
In vitro NPC migration assay. In vitro NPC migration assay was per-
formed as previously described (Moors et al., 2007; Huang et al., 2012).
Briefly, neurospheres derived fromNPCs at the seventh day were treated
with 5 g/ml mitomycin C (Sigma-Aldrich) for 2 h (Shikatani et al.,
2012), plated on a poly-lysine-coated 24-well plate (Corning), and cul-
tured in the presence of Tat-containing conditioned media or recombi-
nant Tat protein for 16 h. Thirty neurospheres were randomly selected
from each sample. Images of those neurospheres were taken. The dis-
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tance from the edge of each neurosphere to the farthestmigrated cells was
measured as the migration distance.
In vitro NPC differentiation assay. In vitro NPC differentiation assay
was performed as described previously with somemodifications. Briefly,
neurospheres derived from NPCs at the seventh day were plated on a
poly-lysine-coated coverslips in a 24-well plate (Corning) or a poly-
lysine-coated 6 cm plate, and cultured in the presence of Tat-containing
conditioned media or recombinant Tat protein for 7 d. The cells were
processed for immunofluorescence staining (from a 24-well plate) or
harvested for Western blotting (from a 6 cm plate).
Preparation of Tat-containing conditioned media. Mouse primary as-
trocytes were isolated from iTat or WTmice, cultured in the presence of
Dox (5g/ml) for 3 d, thoroughly rinsed with PBS three times to remove
Dox and FBS, refilledwithNPC culturemediumdescribed above orNPC
differentiation medium (Neurobasal-A medium supplemented with 2%
FBS, 50 U/ml penicillin, and 50 g/ml streptomycin), and continued to
culture for 24 h. The supernatants were collected as Tat-containing con-
ditioned media. Alternatively, human primary astrocytes were trans-
fected with pcDNA3 or pTat.Myc, cultured for 16 h, thoroughly rinsed
with PBS three times, refilled with NPC culture medium or NPC differ-
entiation medium described above, and continued to culture for 48 h.
The supernatants were collected, cleared of cell debris, and saved as Tat-
containing conditioned media from human primary astrocytes.
Western blotting. Cells were washed twice with ice-cold PBS and lyzed
inRIPAbuffer [50mMTris.HCl, pH7.4, 150mMNaCl, 1%TritonX-100,
1% sodium deoxycholate, 0.1% SDS, 2 mM PMSF, and 1 protease
inhibitor mixture (Roche)] on ice for 20 min for whole-cell lysate prep-
aration. Protein concentration was determined using a Bio-Rad DC pro-
tein assay kit (Bio-Rad). Cell lysateswere electrophoretically separated by
10% SDS-polyacrylamide gel for Western blotting with appropriate pri-
mary antibodies: mouse monoclonal -NeuN (Millipore), goat poly-
clonal -doublecortin (DCX; Santa Cruz Biotechnologies), rabbit
polyclonal -GFAP (DAKO), mouse monoclonal -Hes1 (Santa Cruz
Biotechnologies), and mouse monoclonal --actin (Sigma-Aldrich),
followed by ECL detection and imaging using a Bio-Rad ChemicDoc
imaging system.
Immunofluorescence staining for neurospheres. Neurospheres were
washed with ice-cold PBS at room temperature and fixed with 4% para-
formaldehyde for 30 min, and followed by permeabilizing with 0.5%
Triton X-100 in PBS for 30min and blocking with PBS-BB (5% BSA, 1%
nonfat milk and 0.3% Triton X-100 in PBS) for 1 h. Then, neurospheres
were incubated in mouse monoclonal -MAP-2 (1:200; Santa Cruz Bio-
technologies) and rabbit polyclonal -glial fibrillary acidic protein (-
GFAP; 1:200; DAKO) in PBS-BB at 4°C overnight, and goat anti-mouse
Alexa fluor 555 (1:500; Life Technologies) and goat anti-rabbit Alexa
fluor 488 (1:500, Life Technologies) in PBS-BB at room temperature for
1 h. Nuclei were counterstained with 0.1 g/ml 4, 6-diamidino-2-
phenylindole (DAPI). Extensive washes with PBS were performed be-
tween each step. Omission of the primary antibody in parallel staining
was included as a control to ensure no nonspecific staining. ImageJ soft-
ware (NIH)was used to quantify the fluorescence intensity of the staining
samples.
Floating staining for mouse brain tissues and quantification. Optimal
cutting temperature (OCT) compound-embedded brainswere sectioned
(30 m thick) throughout the rostrocaudal extent of the hippocampal
dentate gyrus of the mouse brain using a cryostat (Leica). A one-in-six
series of floating sections were washed in PBS three times, 5 min each
time to remove cryobuffer and the OCT compound. Then the section
was incubated in 0.2N HCl at room temperature for 1 h, in 10 mM
sodiumborate for 10min, and in PBS-BB for 1 h, then incubatedwith rat
monoclonal -BrdU (1:100; Thermo Fisher Scientific) or mouse poly-
clonal -NeuN (1:100; Millipore) in PBS at 4°C overnight, and with goat
anti-mouse Alexa fluor 555 (1:500; Life Technologies) and goat anti-
rabbit Alexa fluor 488 (1:500; Life Technologies) in PBS-BB at room
temperature for 1 h. Nuclei were counterstained with 0.1 g/ml DAPI.
Extensive washes with PBS were performed between each step. Omission
of the primary antibody in parallel staining was included as a control to
ensure no nonspecific staining. The number of the GFPBrdU or
NeuNBrdU cells in the brain was stereologically counted essentially
as previously described (Gao and Chen, 2013).
-Galactosidase and luciferase reporter gene assays. Cells were washed
twice with ice-cold PBS, suspended with 200 l 1 reporter lysis buffer
(Promega), and incubated at room temperature for 5min. The clear super-
natant was collected by brief centrifugation. For -galactosidase reporter
gene assay, 10 l cell lysates were mixed with 3 l of 100Mg2 solution
(0.1 MMgCl2 and 4.5 Mmecaptoethanol, 66l of 4 ng/ml o-nitrophenyl-D-
galactopyranoside in 0.1 M sodium phosphate, pH 7.5, and 201 l of 0.1 M
sodium phosphate, pH 7.5. The mixture was incubated at 37°C for 30 min.
The optical density at 405 nm wavelength was determined using a Bio-Rad
iMarkmicroplate reader. The-galactosidase activitywas used tonormalize
the transfection variations among transfections for the subsequent luciferase
reporter gene assay, which was conducted using a luciferase assay system
(Promega). The luciferase activity was quantitated using an Opticomp Lu-
minometer (MGM Instruments).
Data analysis.All experiment data were analyzed by one-way ANOVA
and two-tailed Student’s t test. A p value 0.05 was considered to be
statistically significant and marked with an asterisk.
Results
Impaired neurogenesis in the dentate gyrus of the
hippocampus of Tat-expressing mice
To determine effects of HIV Tat expression on neurogenesis, we
took advantage of the iTat mice and the nestin-GFP mice. When
given Dox, iTat mice express a physiological level of Tat protein
in the CNS and induce a variety of neuropathological and neu-
robehavioral changes reminiscent ofHIV/neuroAIDS (Kim et al.,
2003). GFP expression in nestin-GFP mice allows accurate and
sensitive determination of nestin (namely, GFP) NPCs (Mi-
gnone et al., 2004). Nestin-GFP mice were crossbred with iTat
mice to generate nestin-GFP/iTat mice. Both nestin-GFP mice
and nestin-GFP/iTat mice were given Dox. Tat expression in
those mice were confirmed as previously described (Kim et al.,
2003; Zou et al., 2010; Fan et al., 2011, 2015). Compared with
nestin-GFP mice, nestin-GFP/iTat mice had considerably fewer
GFPNPCs in the dentate gyrus of the hippocampus (Fig. 1A,B,
GFP column,D). Similarly, the number of cells positive for DCX,
amarker for immature neurons in the early neurogenesis (Brown
et al., 2003; Mishra et al., 2010), in the dentate gyrus of the hip-
pocampus of nestin-GFP/iTat mice was considerably lower than
the comparable number in nestin-GFP mice (Fig. 1A, DCX col-
umn, E). In addition, the number of cells positive for GFAP, a
marker for astrocytes (Eng and Ghirnikar, 1994), in the dentate
gyrus of the hippocampus of nestin-GFP/iTat mice was consid-
erably higher than the comparable number in nestin-GFP mice
(Fig. 1B, GFAP column, F).
Next, nestin-GFP and nestin-GFP/iTat mice were given Dox
as well as BrdU for a shorter period of time. NPC proliferation
(GFPBrdU cells) in both mice was determined (Fig. 2A).
Compared with nestin-GFP mice, nestin-GFP/iTat mice have
significantly fewer GFPBrdU cells in the dentate gyrus of the
hippocampus (Fig. 2B). Last, after WT and iTat mice were given
Dox as well as BrdU for a longer period of time, the number of
newly produced mature neurons (NeuNBrdU cells) in both
mice was determined. Compared with WT mice, iTat mice have
significantly fewer NeuNBrdU cells in the dentate gyrus of
the hippocampus (Fig. 2B). No GFAPBrdU cells were de-
tected in the dentate gyrus of the hippocampus of both WT and
iTat mice (data not shown), likely due to more rapid astrocyte
proliferation and loss of BrdU signal in the cells. These results
provide the first evidence to support the in vivo association of Tat
expression with fewer NPCs and immature neurons, less NPC
proliferation, and fewer NPC-derived mature neurons in the
dentate gyrus of the hippocampus.
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HIV Tat impaired NPC proliferation,
migration, and differentiation in vitro
To further determine the relationship be-
tween Tat expression and neurogenesis,
NPCs were isolated from the mouse brain
and assessed for their proliferation. Condi-
tioned media from Tat-expressing astro-
cytes were first used as a source of
biologically activeTatprotein.Whencondi-
tioned media from Dox-induced mouse
primary astrocytes were used (Fig. 3A), iTat
conditioned medium gave rise to signifi-
cantly smaller NPC-derived neurospheres
than WT conditioned medium (Fig. 3B).
Next, NPC migration was assessed in the
presence of conditionedmedia or recombi-
nant Tat protein. Considering the finding
that HIV-1 Tat inhibits cell proliferation
(Viscidi et al., 1989; Prakash et al., 2001;
Zhou and He, 2004), which may not allow
us to distinguish Tat-impaired NPCmigra-
tion from Tat-induced inhibition of NPC
proliferation, we treated neurospheres first
with mitomycin C to inhibit neurosphere
proliferation (Shikatani et al., 2012) and
then with Tat-containing conditioned me-
dia, and determined Tat effects on the neu-
rosphere migration. Conditioned medium
from Dox-induced iTat mouse primary as-
trocytes showed a significantly shorter NPC
migration distance than that from Dox-
inducedWTmouseprimaryastrocytes (Fig.
3C,D). Last, NPC differentiation was as-
sessed in the presence of conditionedmedia
or recombinant Tat protein. Compared
with the mock and WT controls, iTat con-
ditioned medium decreased DCX and
NeuN expression and increased GFAP ex-
pression inNPC-derivedneurospheres over
time by Western blotting (Fig. 3E) and de-
creased MAP-2 expression and increased
GFAP expression in neurospheres by im-
munofluorescence staining (Fig. 3F).
Similar results on NPC proliferation
were obtained with conditioned media
fromTat-transfectedhumanprimary astro-
cytes (Fig. 4A,B). Given the possible pres-
ence of other unknown soluble factors in
Tat-containing conditioned media, NPC
proliferation was directly assessed using re-
combinant Tat protein. More Tat protein
was associated with the formation of signif-
icantly smaller NPC-derived neurospheres
(Fig. 4C,D).A significantly shorterNPCmi-
grationdistancewas alsonotedwhencondi-
tioned medium from Tat-transfected
human primary astrocytes (Fig. 5A) or re-
combinant Tat protein was used (Fig. 5B).
Recombinant Tat protein also gave rise to
similar results on NPC differentiation (Fig.
6A,B). Furthermore, conditioned medium
from Tat-expressing human primary astro-
cytes were immunodepleted of Tat and as-
Figure 1. Fewer NPC (GFP) and immature neurons (DCX) in the dentate gyrus of the hippocampus of Tat-
expressing mouse brain. Four-week-old nestin-GFP mice and nestin-GFP/iTat mice were intraperitoneally injected with
Dox for 7 d. A, B, The brains were collected, sectioned, and stained with anti-DCX antibody (A) or anti-GFAP antibody (B),
followed by donkey anti-goat Alexa fluor 555. The brain sections were then counterstained with DAPI for nuclei, and the
micrographs were taken from comparable regions of the dentate gyrus of the hippocampus of the brains (3 mice in each
group). The images were representative of all the stained brain sections in each group. C–F, ImageJ software (NIH) was
used to quantify the relative immunofluorescence intensity of each staining. The surrounding background was subtracted.
DAPI (C) was used as a reference to compare the signal intensity of GFP (D), DCX (E), or GFAP (F ). The data were mean
SD of three brains in each group.
Figure 2. Decreased NPC proliferation (GFPBrdU) and fewermature neurons (NeuNBrdU) in the dentate gyrus
of the hippocampus of Tat-expressing mouse brain. A, B, Four-week-old nestin-GFP mice and nestin-GFP/iTat mice were
intraperitoneally injected with Dox for 4 d and then Dox plus BrdU for 3 d. Mouse brains were collected, sectioned, and
stained with anti-BrdU antibody, followed by donkey anti-rat Alexa fluor 555. The dentate gyrus of the hippocampus of the
brains from each group was photographed (A, left). Inset (A, right) shows portion of image under high magnification.
GFPBrdU cells were stereologically counted (B). The data were mean  SD. of three brains in each group. C, D,
Eight-week-old WT and iTat mice were intraperitoneally injected with Dox for 4 d, Dox plus BrdU for 3 d, and BrdU alone for
4 d. Mouse brains were collected 25 d after the final injection, and stained with anti-BrdU and anti-NeuN antibody,
followed by donkey anti-rat Alexa fluor 555 and goat anti-mouse Alexa fluor 488. The dentate gyrus of the hippocampus
regions of the brains for each staining were photographed (C, left). Inset (C, right) shows portion of image under high
magnification. NeuNBrdU cells were stereologically counted in the dentate gyrus of the hippocampus of iTat-induced
and WT-induced mouse brain (D). The data were mean SD. of three brains in each group.
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sessed for its effects on NPC differentiation. Compared with the
isotype-matched IgG control, Tat depletion restored normal DCX,
NeuN, and GFAP expression in the neurospheres (Fig. 7A). Heat
inactivation of recombinant Tat protein showed similar results
(Fig. 7B).
To ensure that the viability of the neurospheres with different
treatments were comparable, the LDHcytotoxicity assaywas per-
formed with neurospheres treated with Tat-containing condi-
tioned media or recombinant Tat protein. Compared with the
controls, no significant cytotoxicity in neurospheres was detected
in neurospheres treated with Tat-containing conditioned media
or recombinant Tat protein (data not shown). In addition, to
address the physiological relevance of the findings above, the
TZM-bl-based reporter gene assay was performed to determine
Figure3. ImpairedNPCproliferation,migration, anddifferentiationby Tat-containing conditionedmedia.Neurospheres derived frommouseNPCs at the seventhdayof cultureswere trypsinized
to obtain single cells. A, B, The single cells were cultured in a nontreated 12-well plate in the presence of conditionedmedium from Dox-inducedWT and iTat mouse primary astrocytes for 7 d (A),
followedby quantitation of the sizes of neurospheres (B, open bars: diameter of neurospheres,60m; closed bars: diameter of neurospheres,60m). C,D, Neurospheres derived frommouse
NPCs at the seventh day of cultures were cultured in a poly-lysine-coated 24-well plate in the presence of mitomycin C for 2 h and then conditionedmedium from Dox-inducedWT and iTat mouse
primary astrocytes for 16 h, followed by quantitation of the migration distance from the center of 30 randomly selected neurospheres. E, F, The single cells were cultured in a poly-lysine-coated
24-well plate in the presence of conditionedmedium from Dox-inducedWT and iTat mouse primary astrocytes for 2, 4, and 8 d, followed byWestern blotting (E) and immunofluorescence staining
(F; at day 8). The single cells cultured in the NPCmediumwere included as amock control (E). The images/blots were representative of all the neurospheres in each sample. The data weremean
SD of triplicates in each group and representative of three independent experiments.
Figure 4. Impaired NPC proliferation by Tat-containing conditionedmedia and recombinant Tat protein. Neurospheres derived frommouse NPCs at the seventh day of cultures were trypsinized
to obtain single cells.A–D, Those single cells were cultured in the presence of conditionedmedia from Tat-transfected and C3-transfected human primary astrocytes (A), or recombinant Tat protein
(C) for 7 d, followed by quantitation of the sizes of neurospheres (B, D, open bars: diameter of neurospheres,60 m; closed bars: diameter of neurospheres,60 m). The images were
representative of all the neurospheres in each sample. The data were mean SD of triplicates in each group and representative of three independent experiments.
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the level of Tat protein in the Tat-containing conditionedmedia.
The level of Tat protein in the Tat-containing conditionedmedia
was found to be in the range of 1–5 ng/ml (data not shown),
which is close to the reported Tat concentration in the brains of
HIV-infected individuals (Westendorp et al., 1995; Xiao et al.,
2000). Together, these results support the notion that Tat directly
alters NPC proliferation, migration, and differentiation.
Activation of Notch signaling by HIV Tat
Notchsignaling(activation) is elicitedbybindingofNotch ligands to
the extracellular domain of the Notch receptors, followed by activa-
tion of downstream genes, such as transcription factor hairy and
enhancer of split-1 (Hes1; Kageyama and Ohtsuka, 1999). One or
moreepidermalgrowth factor (EGF)-likemotifs arepresented in the
extracellular domain of all the Notch isoforms and their respective
ligands, andaredirectly involved inNotch/ligand interactions (Chil-
lakuri et al., 2012). In our previous study, we identified several Tat-
binding proteins (Liu et al., 2002; data not shown), the majority of
which possess 1 EGF-like motifs. HIV-1 Tat has indeed been
shown to bind to the EGF-like motifs within the extracellular do-
main of the Notch receptor (Shoham et al., 2003a). These findings
led us to propose that Tat might function as a Notch ligand and
regulate neurogenesis through binding to the Notch receptor and
subsequently activating Notch signaling. To test this hypothesis,
Notch downstream geneHes1 promoter-driven luciferase (Luc) re-
porter was transfected with an increasing amount of Tat. Then Luc
activity was determined and used as an indirect indictor of Notch
signaling activation. Significant levels of the Luc activity were de-
tected in cells transfected with Hes1-Luc and 0.1 and 0.2 g of Tat
expression plasmids (Fig. 8A). Next, Hes1 protein expression was
determined inNPC-derived neurospheres using conditionedmedia
from Dox-induced WT and iTat mouse primary astrocytes. Com-
pared with the mock and WT controls, iTat conditioned medium
showed increased Hes1 protein expression in NPC-derived neuro-
spheres (Fig. 8B). Recombinant Tat treatment also increased Hes1
Figure 5. Impaired NPC migration by Tat-containing conditioned media and recombinant
Tat protein. Neurospheres derived from mouse NPCs at the seventh day of cultures were
trypsinized to obtain single cells. A, B, The single cells were cultured in the presence of condi-
tionedmedia from Tat-transfected and C3-transfected human primary astrocytes (A) or recom-
binant Tat protein (B) for 48 h, followed by quantitation of the migration distance from the
center of 20 randomly selected neurospheres. The data were mean SD of triplicates in each
group and representative of three independent experiments.
Figure 6. Impaired NPC differentiation by recombinant Tat protein. Neurospheres derived
from mouse NPCs at the seventh day of cultures were trypsinized to obtain single cells. A, B,
Those single cellswere cultured in the presence of 0, 2, and 5 ng/ml recombinant Tat protein for
2, 4, and 8 d and harvested for Western blotting (A) or stained for MAP-2, GFAP antibodies,
followed by goat anti-mouse Alexa fluor 555 and goat anti-rabbit Alexa fluor 488 and DAPI (B;
only for neurospheres at day 8). The blots/images were representative of all the stained neuro-
spheres in each group and were representative of three independent experiments.
Figure 7. Rescue of normal NeuN, DCX, and GFAP expression in neurospheres by Tat immu-
nodepletion and heat inactivation. Neurospheres derived frommouse NPCs at the seventh day
of cultures were trypsinized to obtain single cells. A, B, The single cells were cultured in the
presenceof conditionedmediaandTat-immunodepleted conditionmedia fromTat-transfected
or C3-transfectedhumanprimary astrocytes for 8 d andharvested forWestern blotting (A), or in
the presence of 5 ng/ml recombinant Tat or heat-denatured recombinant Tat (Tat #) for 8 d and
harvested for Western blotting (B). Isotype-matched IgG was used as an immunodepletion
control (A). PBS was included as a solvent control (B). The data were representative of three
independent experiments.
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protein expression, while heat-inactivated Tat did not show much
change (Fig. 8C). Furthermore, increased Hes1 protein expression
by Tat-expressing conditioned medium was abrogated by immu-
nodepletion of Tat from the conditioned medium (Fig. 8D). These
results demonstrated that Tat-containing conditioned media or re-
combinant Tat protein were capable of inducingHes1 expression at
bothmRNA and protein levels.
HIV Tat protein has a cysteine-rich domain adjacent to the N
terminus of the protein. This domain is important for Tat transacti-
vation activity on the HIV LTR promoter and binding to other cel-
lular cofactors (Shoham et al., 2003a; Ranga et al., 2004). An early
study has shown that cysteines within the cysteine-rich domain of
the Tat protein from the caprine arthritis encephalitis virus, a retro-
virus closely related to HIV, are directly involved in Tat interaction
with the EGF-like motifs of the Notch receptor (Shoham et al.,
2003b). Thus, we next determined the specificity of the relationship
betweenHes1activationandTat/Notch interactionusinga setofTat
mutants derived from subtype C HIV strains WT Tat (Tatcs; Tat
with cysteine at amino acid residue 30 and serine at amino acid
residue 31) and mutants Tatcc (the WT cysteine-rich domain of
subtypeCTat replacedwith that of subtype BTat, inwhichTatwith
cysteine at both amino acid residue 30 and amino acid residue 31),
and Tatsc (Tat with serine at amino acid residue 30 and cysteine at
amino acid residue 31; Ranga et al., 2004). First, Tatcs, Tatcc, and
Tatsc were assessed for their activity on Hes1-Luc reporter gene ex-
pression. Compared with the C3 control, Tatcs and Tatcc activated
Hes1-Luc expression, albeit at a lower level than Tat derived from
NL4-3subtypeBHIVstrain (Fig. 9A). Incontrast,Tatsc showed little
effect on Hes1-Luc expression. Despite the findings that Tat is se-
creted outside Tat-expressing cells to function as a ligand to interact
with the extracellular domain of the Notch receptor, it was impera-
tive to ascertain that extracellular Tat could indeed transactivate
Hes1-Luc expression. Thus, conditioned media from Tat-trans-
fectedhumanprimaryastrocyteswereaddedtocells transfectedwith
the Hes1-Luc reporter gene. Cells transfected with HIV-1 LTR-Luc
were included to monitor Tat biological activity. Similarly to direct
transfection (Fig. 9A), conditioned media from Tat-expressing,
Tatcs-expressing, and Tatcc-expressing cells, but not those from
Tatsc-expressing cells, transactivated Hes1-Luc expression (Fig. 9B,
open bars). As shown above, conditioned media from Tat-express-
ing, Tatcs-expressing, and Tatcc-expressing cells, but not those from
Tatsc-expressing cells, transactivatedHIV LTR-Luc expression (Fig.
9B, closed bars). In addition, the same conditionedmedia were also
added toNPC-derivedneurospheres andassessed for their effects on
NPC differentiation. Compared with the C3 control, conditioned
media from Tatcs-expressing and Tatcc-expressing cells increased
Hes1 protein expression and GFAP expression in the neurospheres
anddecreasedDCXandNeuNexpression inneurospheres, but con-
ditionedmedia fromTatsc-expressingcells showed little change(Fig.
9C). Together, these results indicate that Tat functions as a Notch
ligand and likely regulates neurogenesis through binding of the Tat
cysteine-rich domain to the EGF-likemotifs within the extracellular
domain of the Notch receptor and activation of the Notch signaling
pathway.
Inhibition of Notch signaling significantly alleviated
Tat-impaired NPC differentiation in vitro and neurogenesis
in vivo
To determine the significance of Tat/Notch signaling in Tat-
impairedNPCdifferentiation in vitro, we took advantage of twowell
characterized inhibitors ofNotch signaling.One isDAPT,which is a
-secretase inhibitor and an indirect inhibitor of Notch, a -secre-
tase substrate (Netzer et al., 2010). The other is delta-like 1 homolog
(DLK1), which is one of the noncanonical Notch ligands and acts as
a competitive ligand to inhibit Notch signaling (Falix et al., 2012;
Rodríguez et al., 2012). Jaaged-1 was included as the constitutive
Notch ligand and a positive control for Notch signaling (Ba et al.,
2012). DAPT, DLK1, Jagged-1, or DLK1 plus Jagged-1 were in-
cluded in the NPC-derived neurosphere cultures treated with con-
ditioned media from Dox-induced WT and iTat mouse primary
astrocytes. Compared with the respective mock control, DAPT or
DLK1 only had a subtle effect on Hes1, DCX, NeuN, and GFAP
expression in neurospheres treated with WT conditioned medium,
but significantlydecreasedHes1andGFAPexpressionand increased
DCX and NeuN expression in neurospheres treated with iTat con-
ditioned medium (Fig. 10A). Jagged-1 increased Hes1 and GFAP
expression and decreased DCX and NeuN expression in neuro-
spheres in both WT and iTat conditioned media, while DLK1 plus
Jagged-1 abrogated the changes. Compared with the WT control,
iTat conditioned medium increased Hes1 and GFAP expression in
the neurospheres and decreased DCX and NeuN expression in the
neurospheres (Fig. 10A).Next,Notch signaling inhibitorDAPTwas
assessed for its effects on Tat-impaired neurogenesis using the iTat
mice. DAPT was given to mice along with Dox and BrdU. Newly
Figure 8. Transactivation of Hes1 expression by HIV-1 Tat. A, Human primary astrocytes
were transfectedwithHes1promoter-driven luciferase reporter genewith 0, 0.01, 005, 0.1, and
0.2 g of Tat expression plasmid. Cells were harvested 72 h after transfection for luciferase
reporter gene assay. C3 was included to equalize the total amount of transfected DNA. pCMV-
-gal was used to normalize the transfection efficiency variations among all transfections.
Statistical analysis was performed using C3-transfected cells (open bar) as the reference. The
data were mean SD of triplicates and representative of three independent experiments.
B–D, Neurospheres derived frommouseNPCs at the seventh day of cultureswere trypsinized to
obtain single cells. The single cells were cultured in the presence of conditioned medium from
Dox-induced WT and iTat mouse primary astrocytes (B), recombinant Tat and heat-denatured
recombinant Tat (C, Tat #), or conditioned media and Tat-immunodepleted condition media
from Tat-transfected or C3-transfected human primary astrocytes (D) for 8 d and harvested for
Western blotting. The single cells cultured in the NPCmediumwere included as amock control
(B). PBS was included as a solvent control (C). Isotype-matched IgG was used as an immu-
nodepletion control (D).-Actinwas includedas anequal loading control (B–D). Thedatawere
representative of three independent experiments.
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produced neurons, namely BrdUNeuN
cells, were determined 25 d after the final
injection.Comparedwith the respective sol-
vent control, DAPT had no effects on the
number of BrdUNeuN cells in the den-
tate gyrus of the hippocampus ofWTmice,
but significantly increased the number of
BrdUNeuN cells in the dentate gyrus of
the hippocampus of iTat mice (Fig. 10B).
Those inhibitors exhibited similar effects on
Hes1,DCX,NeuN, andGFAPexpression in
neurospheres treated with recombinant Tat
protein (Fig. 11). These results provide fur-
ther evidence to support the direct invo-
lvement of Tat interaction with Notch
signaling in Tat-impaired neurogenesis.
Discussion
In the study, we aimed to determine Tat
effects on neurogenesis. Using a com-
bined genetic, molecular, cellular, and
biochemical approach, we have demon-
Figure 11. Inhibition of Notch signaling and rescue of normal NeuN, DCX, and GFAP expression in neurospheres altered by
recombinant Tat. Neurospheres derived frommouseNPCs at the seventh day of cultureswere trypsinized to obtain single cells. The
single cells were cultured in the presence of 5 ng/ml recombinant Tat protein and Notch inhibitors DAPT (5g/ml) and DLK1 (500
ng/ml), Notch activator Jagged-1 (100 ng/ml), or DLK1 plus Jagged-1 for 8 d and harvested forWestern blotting. PBSwas used as
the solvent control. The blots were representative of three independent experiments.
Figure 9. Requirement of cysteine at amino acid residue 30 for Tat-mediated Hes1 transactivation.A, Human primary astrocytes were transfectedwithHes1 promoter-driven luciferase reporter
genewithpTat.Myc, pC-Tat CS, pC-Tat CC, or pC-Tat SC. Cellswereharvested72hafter transfection for the luciferase reporter gene assay.B, Humanprimary astrocyteswere transfectedwithpTat.Myc,
pC-Tat CS, pC-Tat CC, or pC-Tat SC. Supernatantswere collected 72 h after transfection and used to treat pHes1-Luc-transfected humanprimary astrocytes (B, open bars) or pLTR-Luc-transfected 293T
cells (B, closed bars). Cells were harvested for the luciferase activity assay 24 h after treatment. C3 was included to equalize the transfected DNA. pCMV--gal was included to normalize the
transfection efficiency variations among all transfections. Statistical analysis was performed using C3-transfected cells as the reference. The data weremean SD of triplicates and representative
of three independent experiments. C, The same supernatants were added on the single cells derived from neurospheres formed on the seventh day. After culturing for 8 d, neurospheres were
harvested for Western blotting.-Actin was included as an equal loading control. The blots were representative of three independent experiments.
Figure 10. Inhibition of Notch signaling and rescue of impaired neurogenesis by Tat. A, Neurospheres derived frommouse NPCs at the seventh day of cultures were trypsinized to obtain single
cells. The single cellswere cultured in the presence of conditionedmedia fromDox-inducedWTand iTatmouse primary astrocytes andNotch inhibitors DAPT (5g/ml) andDLK1 (500ng/ml), Notch
activator Jagged-1 (100 ng/ml), or DLK1 plus Jagged-1 for 8 d and harvested forWestern blotting. The blots were representative of three independent experiments.B, Eight-week-oldWT and iTat
micewere intraperitoneally injectedwith Dox and DAPT for 4 d; with Dox, BrdU, and DAPT for 3 d; andwith BrdU alone for 4 d. Mouse brains were collected 25 d after the final injection, and stained
with anti-BrdU and anti-NeuN antibody antibodies, followed by donkey anti-rat Alexa fluor 555 and goat anti-mouse Alexa fluor 488. NeuNBrdU cells were stereologically counted in the
dentate gyrus of the hippocampus of iTat-induced andWT-induced mouse brain. The data were mean SD. of three brains in each group.
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strated that Tat adversely regulates adult neurogenesis through its
alterations on NPC proliferation, migration, and differentiation.
The nature of Tat being a secretory protein and readily being
taken up into neighboring cells may allow Tat from astrocytes in
our experimental setting to directly interact with NPCs and lead
to inhibition of their proliferation (Figs. 1A, 2, 4A–D) andmigra-
tion (Figs. 3A–D, 5A,B) and to alterations in their differentiation
(Figs. 3E,F, 6A,B). Tat protein interacts with a number of cell
cycle regulators or downregulates cellular genes and inhibits pro-
liferation of various cells, including NPCs, astrocytes, and neu-
rons (de la Fuente et al., 2002; Canani et al., 2003; Zhou and He,
2004; Nyagol et al., 2006; Toschi et al., 2006; Mishra et al., 2010;
Zhang et al., 2012). Several chemokine receptors are expressed on
NPCs (Ji et al., 2004), which could be engaged by chemotactic Tat
protein itself (Albini et al., 1998) or chemokines induced by Tat
in astrocytes (Bonwetsch et al., 1999; Kim et al., 2004; Hahn et al.,
2010; Fitting et al., 2014), thus affecting NPC migration. Tat
protein has also been shown to alter differentiation of mesenchy-
mal stem cells and other cells (Zauli et al., 1994;Wang et al., 2002;
Gibellini et al., 2010, 2012). However, given the extremely low
level of Tat expression in the brain of iTat mice and recombinant
Tat protein used in the in vitro assays, there is little if any chance
that Tat affects NPCs and neurogenesis.
Notch signaling plays an essential role in neurogenesis in both
the developing brain and the adult brain, including NPC prolif-
eration, migration, and differentiation in developing and adult
brains, and in neurite remodeling, synaptic plasticity, and learn-
ing and memory in the adult brain, and is involved in neurolog-
ical disorders, such as neurodegenerative diseases (Ge et al., 2002;
Mizutani and Saito, 2005;Miller andGauthier, 2007; Lathia et al.,
2008; Latasa et al., 2009). Our findings that Tat activates the
downstream Hes1 gene of the Notch signaling pathway through
direct binding (Figs. 8, 9) and that inhibition of Tat-elicited
Notch signaling restores normal NPC differentiation (Figs. 10,
11) support the notion that Tat interaction with the Notch sig-
naling pathway is mainly responsible for Tat-induced changes in
NPC proliferation, migration, and differentiation, and in neuro-
genesis. Alternatively, Tat could regulate neurogenesis through
its interaction with astrocytes, particularly in the iTat mouse
model in which Tat expression is under the control of both Dox
and the GFAP promoter (Kim et al., 2003) and Tat and GFAP
expression form a positive feedback loop, leading to more GFAP
expression or astrocytosis (Figs. 3E,F, 6). Although Tat inhibits
astrocyte proliferation (Viscidi et al., 1989; Prakash et al., 2001; de
la Fuente et al., 2002; Canani et al., 2003; Zhou and He, 2004;
Nyagol et al., 2006), Tat activates GFAP expression through a
cascade of transcriptional network (Zhou et al., 2004; Zou et al.,
2010; Fan et al., 2011, 2015). Thus, it is reasonable to assume that
Tat-induced astrocytosismainly results from increasedGFAP ex-
pression. In addition, the GFAP promoter is active in neural stem
cells (Doetsch et al., 1999; Imura et al., 2003). Tat expression in
neural stem cells could lead to more GFAP expression (Fig. 1B).
Increased GFAP expression alone has been linked to reduced
NPC proliferation, fewer immature neurons, and abnormal NPC
differentiation and neurogenesis (Hagemann et al., 2013). It is
also plausible that Tat/Notch signaling interacts with other
physiologically intrinsic signaling pathways in regulating NPC
proliferation, migration, differentiation, and neurogenesis. For
example, bone morphogenetic proteins promote dorsal neural
formation in the brain (Liu and Niswander, 2005) and interface
with several pathways, such as Stat3, Wnt, and Shh, to induce
astrocyte specification (Stipursky and Gomes, 2007). Stat3 in-
duces constitutive GFAP expression and Tat-activated GFAP ex-
pression (Fan et al., 2015) and promotes differentiation of
neuron progenitors to astrocytes (Peng et al., 2011). Notch sig-
naling also interfaces with Stat3 via Hes and promotes astrocyte
differentiation (Bonni et al., 1997; Kamakura et al., 2004). In
addition, Notch itself typically downregulates preneuronal gene
expression and inhibits neuron differentiation (Bertrand et al.,
2002). Thus, the Notch pathways activated by Tat binding and
their exact roles in Tat-impaired neurogenesis merit further
investigation.
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